The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of first-line use of cyclin dependent kinase 4/6 (CDK4/6) inhibitors in metastatic breast cancer among Florida health care systems.
 
Reshma L. Mahtani
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo; Eisai; Genentech; Lilly; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; bioTheranostics; Genentech/Roche; Lilly; Novartis; Pfizer; Puma Biotechnology; Seagen
 
Luis E. Raez
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Heat Biologics (Inst); Loxo (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Syndax (Inst)
 
Jessica Unzaga
No Relationships to Disclose
 
Jorge J García
No Relationships to Disclose
 
Krupa Paranjpe
Employment - Pfizer
 
Irene Arias
Employment - Pfizer
 
Aurelio Bartolome Castrellon
No Relationships to Disclose